We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Targeted Destruction of Messenger RNA Regulates Cellular Protein Synthesis

By LabMedica International staff writers
Posted on 14 Oct 2016
Print article
Image: MicroRNA (green) and myogenin mRNA (red) in differentiating C2C12 cells (Photo courtesy of Wikimedia Commons).
Image: MicroRNA (green) and myogenin mRNA (red) in differentiating C2C12 cells (Photo courtesy of Wikimedia Commons).
Researchers have proposed a mechanism that explains how cells regulate protein synthesis by coordinating the destruction of messenger RNA (mRNA) in the cytoplasm.

Messenger RNA carries the instructions genes from the nucleus of a cell into the cytoplasm where it teams up with ribosomes to manufacture protein. As long as the mRNA remains functional, protein synthesis can continue. It was not known how the cell controlled the amount of protein to make.

Investigators at Case Western Reserve University (Cleveland, OH, USA) and Johns Hopkins University (Baltimore, MD, USA) have now proposed a mechanism to explain how levels of cellular protein synthesis are controlled.

The master regulator is the enzyme called DEAD-box protein Dhh1p. DEAD box proteins are involved in an assortment of metabolic processes that typically involve RNAs, but in some cases also other nucleic acids. They are highly conserved in nine motifs and can be found in most prokaryotes and eukaryotes, but not all. Many organisms, including humans, contain DEAD-box helicases, which are involved in RNA metabolism.

The investigators reported in the September 15, 2016, online edition of the journal Cell that Dhh1p physically interacted with ribosomes in vivo. It was a sensor of codon optimality that targeted an mRNA for decay. Messenger RNAs whose translation elongation rate was slowed by inclusion of non-optimal codons were specifically degraded in a Dhh1p-dependent manner. Biochemical experiments showed that Dhh1p was preferentially associated with mRNAs with suboptimal codon choice. These effects on mRNA decay were sensitive to the number of slow-moving ribosomes on an mRNA.

“Our study provides a new way to look at the genetic code,” said senior author Dr. Jeff Coller, director of the center for RNA molecular biology at Case Western Reserve University. “We are so used to looking at how DNA mutations cause a change in protein function. We must also consider how enzymes like Dhh1p sense the speed at which ribosomes interpret the genetic code. Now I can look at the genetic code in terms of speed and rate, and with reasonable accuracy predict how much protein is going to come from a gene. There is huge application for that in human biologics, proteins that are easily taken by injection. There are rare genetic diseases attributed to RNA being read too slow or too fast. We can now manipulate this process to dial up or down protein expression. The speed at which the ribosome reads the genetic code and is sensed by Dhh1p could open up a new set of mutation types that could indicate disease states we are unaware of today.”

Related Links:
Case Western Reserve University
Johns Hopkins University
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.